Pathstone Family Office’s Gentex GNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$917K Buy
28,182
+6,008
+27% +$193K 0.01% 751
2023
Q2
$649K Buy
22,174
+11,346
+105% +$313K 0.01% 642
2023
Q1
$307K Sell
10,828
-28,658
-73% -$807K 0.01% 903
2022
Q4
$1.02M Buy
39,486
+751
+2% +$20K 0.01% 788
2022
Q3
$922K Buy
+38,735
New +$1.06M 0.01% 781
2022
Q2
Sell
-5,679
Closed -$256K 1092
2022
Q1
$256K Buy
+5,679
New +$177K 0.01% 813
2021
Q2
Sell
-5,623
Closed -$201K 831
2021
Q1
$201K Buy
5,623
+3,357
+148% +$119K 0.01% 612
2020
Q4
$77K Buy
+2,266
New +$69.9K ﹤0.01% 438
2019
Q4
Sell
-402
Closed -$11K 508
2019
Q3
$11K Buy
402
+2
+0.5% +$53 ﹤0.01% 473
2019
Q2
$10K Buy
+400
New +$9.06K ﹤0.01% 522
2017
Q3
Sell
-2,454
Closed -$47K 236
2017
Q2
$47K Buy
+2,454
New +$47.8K 0.02% 200

Other funds holding GNTX

Pathstone Family Office's GNTX Position: Q3 2023 in Review

Pathstone Family Office increased its Gentex (GNTX) stake by 27% in Q3 2023, buying an estimated $193K and bringing the position to 28,182 shares worth $917K. The position accounts for 0.01% of the portfolio, ranked #751.

Pathstone Family Office first reported a position in GNTX in Q2 2017 and has held it in 11 quarters since. The position peaked at $1.02M in Q4 2022. 498 funds tracked by Wall St. Rank hold GNTX as of Q3 2023.

  • Pathstone Family Office held 28,182 shares of Gentex worth $917K as of Q3 2023.
  • Pathstone Family Office bought 6,008 Gentex shares in Q3 2023, an estimated $193K.
  • Gentex made up 0.01% of Pathstone Family Office's portfolio in Q3 2023, its #751 holding.
  • Pathstone Family Office first reported a position in Gentex in Q2 2017 and has held it in 11 quarters since.
  • Pathstone Family Office's Gentex position peaked at $1.02M in Q4 2022.
  • 498 funds tracked by Wall St. Rank held Gentex as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.